Roche Holding AG (XSWX:ROG)
CHF 251 0 (0%) Market Cap: 201.45 Bil Enterprise Value: 231.01 Bil PE Ratio: 18.96 PB Ratio: 6.91 GF Score: 93/100

Roche Holding AG ASH Virtual Update Event Transcript

Dec 15, 2021 / 03:00PM GMT
Release Date Price: CHF371.3 (+1.60%)
Operator

Kindly note that the webinar is being recorded. (Operator Instructions) One last remark. If you would like to follow the presented slides on your end as well, please feel free to go to roche.com/investors to download the presentation.

At this time, it's my pleasure to introduce you to Karl Mahler, Head of Investor Relations and Group Planning. Karl, the stage is yours.

Karl Mahler
Roche Holding AG - Head of IR

Yes. Thanks a lot, Henrik, for the kind introduction. Welcome to our ASH science call today. This is the last one for this year. It's close to Christmas, and this is also a testimony of the good science, which we had in the past year, I think, on various occasions.

So very excited to present an update on the probably largest and broadest hematology pipeline in the industry. And maybe from my side, to highlight definitely 2 things, there's a lot of things you'll hear today, but maybe 2 things. One is the Phase II for our bispecifics in mosunetuzumab and glofitamab, which got an oral presentation here. And one other highlight definitely

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot